Bml Capital Management, LLC Oramed Pharmaceuticals Inc. Transaction History
Bml Capital Management, LLC
- $170 Billion
- Q3 2024
A detailed history of Bml Capital Management, LLC transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 2,186,191 shares of ORMP stock, worth $5.2 Million. This represents 3.14% of its overall portfolio holdings.
Number of Shares
2,186,191
Previous 1,349,038
62.06%
Holding current value
$5.2 Million
Previous $3.47 Billion
53.86%
% of portfolio
3.14%
Previous 2.47%
Shares
7 transactions
Others Institutions Holding ORMP
# of Institutions
63Shares Held
7.4MCall Options Held
4KPut Options Held
2.1K-
Murchinson Ltd. Toronto, A61.71MShares$4.07 Million1.22% of portfolio
-
Boothbay Fund Management, LLC New York, NY828KShares$1.97 Million0.06% of portfolio
-
Morgan Jess S & CO Inc366KShares$872,0342.07% of portfolio
-
Rathbones Group PLC Liverpool, X0290KShares$689,7310.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny256KShares$608,3280.0% of portfolio
About ORAMED PHARMACEUTICALS INC.
- Ticker ORMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,100
- Market Cap $92.4M
- Description
- Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...